Amrutanjan Health Care Limited (NSE:AMRUTANJAN)
India · Delayed Price · Currency is INR 569.00
+7.95 (1.42%)
Jun 10, 2026, 3:29 PM IST
Amrutanjan Health Care Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 579.18 | 508.35 | 449.73 | 398.35 | 671.89 |
Depreciation & Amortization | 63.19 | 55.7 | 52.08 | 44.18 | 36.56 |
Other Amortization | - | 9.56 | 8.49 | 7.94 | 1.39 |
Loss (Gain) From Sale of Assets | -1.04 | - | -1.57 | -0.27 | - |
Asset Writedown & Restructuring Costs | - | - | 1.11 | - | - |
Loss (Gain) From Sale of Investments | -0.76 | -0.02 | 1.26 | 2.05 | 1.41 |
Stock-Based Compensation | -9.34 | 11.45 | 2.15 | 4.38 | -0.11 |
Provision & Write-off of Bad Debts | 9.17 | 2.64 | 20.99 | 4.64 | 3.99 |
Other Operating Activities | -158.58 | -168.88 | -153.25 | -163.04 | -153.89 |
Change in Accounts Receivable | -57.39 | -81.96 | -169.68 | 47.72 | -209.92 |
Change in Inventory | -100.91 | 16.45 | -0.8 | -28.24 | -85.42 |
Change in Accounts Payable | 29.24 | 146.17 | 95.41 | -106.67 | 236.79 |
Change in Other Net Operating Assets | 6.91 | 9.54 | -26.81 | -9.22 | 19.27 |
Operating Cash Flow | 359.68 | 508.99 | 279.11 | 201.81 | 521.96 |
Operating Cash Flow Growth | -29.34% | 82.36% | 38.30% | -61.34% | -42.56% |
Capital Expenditures | -550.04 | -355.53 | -67.18 | -89.27 | -234.63 |
Sale of Property, Plant & Equipment | 1.04 | - | 2.59 | 0.44 | - |
Investment in Securities | 177.51 | -114.61 | 115.04 | -48.25 | -253.82 |
Other Investing Activities | 159.2 | 160.48 | 141.2 | 112.33 | 126.34 |
Investing Cash Flow | -212.29 | -309.66 | 191.65 | -24.75 | -362.12 |
Long-Term Debt Repaid | -4.96 | -4.61 | -5.57 | -5.8 | -6.92 |
Total Debt Repaid | -4.96 | -4.61 | -5.57 | -5.8 | -6.92 |
Net Debt Issued (Repaid) | -4.96 | -4.61 | -5.57 | -5.8 | -6.92 |
Issuance of Common Stock | 0.72 | 2.38 | 11.79 | - | - |
Repurchase of Common Stock | - | - | -355.02 | - | -35.34 |
Common Dividends Paid | -131.98 | -132.67 | -133.86 | -144.09 | -124.77 |
Financing Cash Flow | -136.22 | -134.9 | -482.66 | -149.89 | -167.02 |
Foreign Exchange Rate Adjustments | - | - | - | - | -0 |
Net Cash Flow | 11.17 | 64.43 | -11.91 | 27.17 | -7.19 |
Free Cash Flow | -190.36 | 153.46 | 211.93 | 112.54 | 287.32 |
Free Cash Flow Growth | - | -27.59% | 88.31% | -60.83% | -67.68% |
Free Cash Flow Margin | -3.79% | 3.40% | 5.03% | 2.96% | 7.08% |
Free Cash Flow Per Share | -6.58 | 5.31 | 7.30 | 3.85 | 9.83 |
Cash Income Tax Paid | 190.31 | 179.23 | 164.97 | 160.63 | 241.92 |
Levered Free Cash Flow | 129.96 | 129.83 | 250.33 | 45.23 | 293.5 |
Unlevered Free Cash Flow | 131.18 | 131.2 | 251.31 | 45.71 | 296.53 |
Change in Working Capital | -122.14 | 90.2 | -101.88 | -96.4 | -39.29 |